Inflammation
Biomarker Library / hs-CRP

hs-CRP

High-Sensitivity C-Reactive Protein

Your cholesterol is fine and nothing hurts. But your arteries can be quietly inflamed for years before they ever say so.

Category Inflammation
Reading Time 8 min
Sources 4 cited
At a Glance
What it is
A high-sensitivity measure of low-grade, body-wide inflammation, the slow-burning process that ages blood vessels and tissue.
Why it matters
Chronic low-grade inflammation independently predicts heart attack, stroke, and overall mortality, often in people whose cholesterol looks reassuring.
Standard range
< 3.0 mg/L
Common guideline threshold
Key lever
Lose visceral fat, move daily, and eat an anti-inflammatory diet; treat hidden sources like gum disease.
Longevity target
< 0.5 mg/L
01 The Question
Why this biomarker matters

Why does this number matter?

Cholesterol tells you how much flammable material is in the building. It says nothing about whether anything is actually on fire.

Plenty of people have a clean lipid panel and a smoldering problem anyway. Their blood vessels are quietly inflamed, their plaque is the unstable kind, their tissues are aging faster than their numbers suggest, and none of it shows up on a standard panel. Inflammation is the process underneath an enormous share of chronic disease, from heart attacks to diabetes to dementia, and for most of a lifetime it makes no noise at all.

hs-CRP is the most accessible way to listen for it. The "high-sensitivity" part is the whole point: ordinary CRP testing is built to detect the roaring inflammation of an infection, while the high-sensitivity assay picks up the faint, persistent signal of the low-grade inflammation that drives long-term disease. A standard panel measures the fuel. This one checks for smoke [1].

02 The Mechanism
What it is and how it works in your body

What is actually happening?

Picture the immune system as a city's emergency dispatch. When trouble breaks out anywhere, an infection, an injury, a patch of damaged artery wall, local responders send up a signal flare. The liver reads those flares and floods the streets with a general-purpose cleanup crew. C-reactive protein is that crew.

A sudden, massive deployment means a real emergency is underway: a flu, a wound, an acute infection. The streets clear once it resolves. That is ordinary CRP, and it is not what we are screening for.

What matters for the long run is different. It is a low, never-ending trickle of crew on the streets, day after day, year after year. Not a blaze, just a haze that never lifts. Somewhere there is a problem the body keeps responding to and never finishes resolving: visceral fat sending out distress signals, a roughened artery wall, inflamed gums, a metabolism under strain. That steady trickle is what the high-sensitivity test is built to catch, and it is the kind of inflammation that quietly wears the body down.

The reading does not tell you where the smoke is coming from. It tells you, unmistakably, that something is still burning.

C-reactive protein is made by the liver, and it is produced on demand in response to a signaling molecule called interleukin-6. When immune cells anywhere in the body encounter damage or infection, they release interleukin-6 into the blood, the liver receives that signal, and within hours it ramps up CRP production [2]. CRP then circulates and binds to the surfaces of dying cells and pathogens, flagging them for removal and activating the broader immune response.

This makes CRP a faithful summary of total inflammatory load. It does not measure any single source. It integrates all of them, which is exactly what makes it useful: a single number reflecting how much inflammatory signaling your body is doing right now.

The high-sensitivity assay matters because the levels that predict chronic disease are very low, often well under 1 mg/L, far below what older CRP tests could reliably read. At these concentrations, the number reflects the background hum of inflammation rather than any acute event. The usual sources of that hum are familiar: visceral fat, which behaves like an inflammatory organ and secretes interleukin-6 directly; insulin resistance; a diet high in refined carbohydrate; smoking; poor sleep; gum disease; and the slow, generalized rise in inflammatory tone that accompanies aging itself, sometimes called inflammaging [3].

Inflammation is also meant to switch off once its job is done, and that resolution is an active process, not just the absence of a signal. The omega-3 fatty acids EPA and DHA supply the raw material for the specialized molecules that carry it out, which is part of why a higher omega-3 status tends to track with a lower CRP [4].

The link between low-grade inflammation and cardiovascular events is one of the most replicated findings in the field. In a meta-analysis pooling more than 160,000 people without a history of vascular disease, each increment of hs-CRP tracked with a higher risk of coronary heart disease, ischemic stroke, and vascular death [1]. The association persisted across populations and held even among people whose cholesterol was unremarkable.

That last point reframed how risk is understood. Lowering atherogenic particles is essential, but a meaningful share of cardiovascular events still occurs in people whose lipids are well managed, and elevated inflammation identifies much of that remaining risk. This is the concept of residual inflammatory risk: two people with identical cholesterol can carry very different danger, and inflammation is part of what separates them [3].

CRP's strength and its weakness are the same trait. Because it integrates inflammation from every source, it is sensitive but not specific. A value above roughly 10 mg/L usually signals an acute event, a cold, an injury, a flare of something, rather than chronic cardiovascular risk, and the test should simply be repeated once recovered. The meaningful screening range sits below that, where a persistently elevated reading points to a chronic, modifiable process. Whether CRP itself drives damage or mainly marks the interleukin-6 pathway that does is still debated, but for practical purposes it does the job that matters: it tells you the fire is lit, early enough to do something about it.

Reference & Optimal Ranges

Optimal
< 0.5 mg/L
Good
< 1.0 mg/L
Caution
1.0 – 3.0 mg/L
Elevated Risk
> 3.0 mg/L

Standard lab reference ranges use different thresholds. Longevity-focused physicians increasingly treat lower levels as actionable. Context matters: family history, other biomarkers, and inflammatory markers all modify interpretation.

03 The System
Biomarkers that work alongside this one

How hs-CRP connects to everything else

hs-CRP does not exist in isolation. It is a downstream signal of several converging metabolic processes, which is why treating it effectively means understanding its inputs.

04 The Timing
When this number changes, and when to test it

When this number moves

🌙
Confirm with a repeat.

A single hs-CRP can be thrown off by a recent cold, a minor injury, or a hard workout. The standard approach is to average two readings taken at least two weeks apart, when you are well, before drawing any conclusion.

❄️
Stay away from it when you are sick.

Acute illness or injury can raise CRP many times over. Wait until you have been recovered for about two weeks so the number reflects your baseline, not a passing event.

🍽️
Intense exercise spikes it briefly.

Hard or unaccustomed training causes muscle inflammation that can elevate CRP for a day or two. Avoid a strenuous session in the 24 to 48 hours before testing.

☀️
It moves over weeks, not days.

CRP responds to sustained change in visceral fat, fitness, and diet across weeks to months. It is a trend marker, so retest on that timescale rather than expecting an overnight shift.

💊
Context raises it.

Pregnancy, estrogen therapy, and higher body fat all lift baseline CRP. None of these are emergencies, but they are worth knowing when you interpret a result.

05 The Changes
What moves it, ranked by evidence

What you can actually change

Listed by strength of evidence, not by how loudly they're sold.

Lose visceral fat
it is the largest single driver of chronic CRP, since abdominal fat secretes inflammatory signals directly. Even modest fat loss lowers CRP measurably
Exercise regularly and build cardiorespiratory fitness
fitter people run lower baseline inflammation, independent of weight
Eat an anti-inflammatory pattern (Mediterranean style)
more vegetables, fiber, legumes, olive oil, and polyphenol-rich foods, less refined carbohydrate
Raise omega-3 intake (fatty fish or algae oil)
omega-3s supply the molecules that resolve inflammation rather than just blunt it
Stop smoking
tobacco is a direct and powerful driver of systemic inflammation
Treat gum disease and dental infection
chronic oral inflammation measurably raises systemic CRP
Protect sleep and address sleep apnea
short or fragmented sleep elevates inflammatory signaling
Cut refined sugar and reduce insulin resistance
metabolic and inflammatory load rise and fall together
Strong evidence (multiple RCTs)
Moderate evidence
Emerging / mechanistic
06 The Reflection
What this biomarker teaches us

Inflammation is the road that many different diseases travel to reach you. Heart disease, diabetes, and cognitive decline look unrelated from the outside, but underneath they share this slow, smoldering process, and for years it asks nothing of you and gives no warning.

hs-CRP is a way to hear it early. It will not name the source, and it does not need to. What it tells you is whether something is burning, and almost everything that turns the number down, losing abdominal fat, moving your body, eating real food, sleeping, not smoking, is already in your hands. Few biomarkers respond as quickly or as fully to the ordinary decisions of a life. This one rewards them. The fire that never starts is the one that never costs you anything.

Order hs-CRP: Price Comparison
$36.95lowest price

hs-CRP is available as a standalone, direct-access test. No doctor's order required. Prices verified March 2026. NY, NJ, and RI residents face restrictions at most services.

Ulta Lab TestsBest price
Quest Diagnostics
Walk-In Labs
Quest Diagnostics, Labcorp
Labcorp OnDemand
Labcorp
Request A Test
Quest Diagnostics, Labcorp
QuestHealth
Quest Diagnostics
HealthLabs.com
Quest Diagnostics, Labcorp
FAQCommon Questions
Do I need to fast before an hs-CRP test?

No. hs-CRP itself does not require fasting. It is often drawn alongside a lipid or metabolic panel that does, so you may end up fasting for the other tests in the same draw.

What level should I aim for?

Below 1.0 mg/L is considered low cardiovascular risk, 1.0 to 3.0 is average, and above 3.0 is high. A longevity-minded target sits under 1.0, and ideally under 0.5.

My hs-CRP came back high. Should I worry?

Not from one reading. A recent cold, injury, or hard workout can raise it temporarily, and a value above 10 mg/L usually means an acute event rather than chronic risk. Repeat the test in two weeks when you are well before concluding anything.

What is the difference between hs-CRP and regular CRP?

They measure the same protein. Regular CRP is calibrated for the high levels of acute infection. The high-sensitivity assay reads the much lower levels that matter for chronic cardiovascular and metabolic risk.

Can I actually lower it?

Yes, and quickly relative to most markers. Losing visceral fat, exercising, improving diet, and quitting smoking can move it substantially within weeks to months.

Does a normal hs-CRP mean I have no inflammation?

Not entirely. CRP is one window on a complex system and will not capture every kind of inflammation. But it is the best-validated, lowest-cost single marker for the low-grade inflammation that tracks with long-term risk.

References
  1. 1.Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. doi:10.1016/S0140-6736(09)61717-7 doi:10.1016/S0140-6736(09)61717-7
  2. 2.Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812. doi:10.1172/JCI200318921 doi:10.1172/JCI200318921
  3. 3.Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016;37(22):1720-1722. doi:10.1093/eurheartj/ehw024 doi:10.1093/eurheartj/ehw024
  4. 4.Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. *Biochemical Society Transactions*. 2017;45(5):1105-1115. doi:10.1042/BST20160474 doi:10.1042/BST20160474